Yi Duan

1.3k total citations
39 papers, 734 citations indexed

About

Yi Duan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yi Duan has authored 39 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Yi Duan's work include Nanoplatforms for cancer theranostics (6 papers), Immune cells in cancer (6 papers) and Immunotherapy and Immune Responses (4 papers). Yi Duan is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Immune cells in cancer (6 papers) and Immunotherapy and Immune Responses (4 papers). Yi Duan collaborates with scholars based in China, United States and Australia. Yi Duan's co-authors include Dong Zhang, Hanshen Yang, Tingbo Liang, Xiaozhen Zhang, Jian Xu, Honggang Ying, Mengyi Lao, Qifeng Yang, Qingshang Yan and Tong Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, ACS Nano and The Journal of Immunology.

In The Last Decade

Yi Duan

35 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Duan China 14 393 142 138 132 121 39 734
Sabrina Ben Larbi France 10 558 1.4× 120 0.8× 92 0.7× 98 0.7× 81 0.7× 17 854
Xiao Sun China 16 398 1.0× 145 1.0× 240 1.7× 94 0.7× 52 0.4× 40 795
Shanbao Cai United States 18 548 1.4× 153 1.1× 328 2.4× 88 0.7× 71 0.6× 35 864
Amin El‐Heliebi Austria 17 278 0.7× 160 1.1× 197 1.4× 98 0.7× 38 0.3× 45 652
Ola Hadadeh Lebanon 12 342 0.9× 181 1.3× 182 1.3× 89 0.7× 35 0.3× 16 676
Zhao Cheng China 18 389 1.0× 93 0.7× 121 0.9× 129 1.0× 39 0.3× 65 781
Hanzhou Wang China 17 503 1.3× 127 0.9× 50 0.4× 119 0.9× 66 0.5× 57 820
Kathrine Woie Norway 16 199 0.5× 162 1.1× 123 0.9× 57 0.4× 67 0.6× 46 710
Robert Wirka United States 14 592 1.5× 68 0.5× 174 1.3× 292 2.2× 139 1.1× 27 1.0k
Xiangyu Zhou China 13 299 0.8× 67 0.5× 120 0.9× 136 1.0× 63 0.5× 43 638

Countries citing papers authored by Yi Duan

Since Specialization
Citations

This map shows the geographic impact of Yi Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Duan more than expected).

Fields of papers citing papers by Yi Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Duan. The network helps show where Yi Duan may publish in the future.

Co-authorship network of co-authors of Yi Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Duan. A scholar is included among the top collaborators of Yi Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Duan. Yi Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bin, Quan Wang, Yi Duan, et al.. (2025). Supramolecular Gels With Controllable Degradation for Suppressing Tumor Recurrence and Relieving Postoperative Pain. Aggregate. 6(4). 1 indexed citations
2.
3.
4.
Gong, Ke, Zhihua Wu, Quan Wang, et al.. (2024). Nanosystem Delivers Senescence Activators and Immunomodulators to Combat Liver Cancer. Advanced Science. 11(20). e2308310–e2308310. 7 indexed citations
5.
6.
Zhou, Jiyong, et al.. (2024). Genomic full‐length sequence of the HLA‐B*40:96 allele was identified by full length group‐specific sequencing. HLA. 104(4). e15686–e15686. 1 indexed citations
7.
8.
Duan, Yi, Xiaozhen Zhang, Honggang Ying, et al.. (2023). Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix. Oncogene. 42(25). 2061–2073. 21 indexed citations
9.
Zhang, Xiaozhen, Mengyi Lao, Jian Xu, et al.. (2022). Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. Journal for ImmunoTherapy of Cancer. 10(3). e003982–e003982. 46 indexed citations
10.
Yang, Hanshen, Xiaozhen Zhang, Mengyi Lao, et al.. (2022). Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell Death and Differentiation. 30(2). 560–575. 44 indexed citations
11.
Wang, Xiaoyu, Yi Duan, Zhifeng Gao, & Jie Gu. (2021). Effect of Goal-directed Fluid Therapy on the Shedding of the Glycocalyx Layer in Retroperitoneal Tumour Resection. Journal of College of Physicians And Surgeons Pakistan. 31(10). 1179–1185. 2 indexed citations
12.
Wang, Kai, et al.. (2020). Identification of the Hub Genes Related to Nerve Injury-Induced Neuropathic Pain. Frontiers in Neuroscience. 14. 488–488. 9 indexed citations
13.
14.
Zhang, Qianwei, et al.. (2020). The relationship between platelet indices and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. European Journal of Pediatrics. 180(3). 699–708. 11 indexed citations
15.
Duan, Yi, Jianye Wang, Songbai Zheng, et al.. (2019). Expert consensus on management of chronic musculoskeletal pain in older adults. Zhonghua laonian yixue zazhi. 38(2). 500–507. 2 indexed citations
16.
Liang, Yiran, Xiaojin Song, Yaming Li, et al.. (2019). Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer. Molecular Therapy — Nucleic Acids. 17. 347–361. 65 indexed citations
17.
Shi, Chengmei, Yi Duan, Zhengqian Li, et al.. (2017). Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats. Behavioural Brain Research. 322(Pt A). 167–176. 13 indexed citations
18.
Song, Guiqin, Kang Liu, Xiaoyan Zhu, et al.. (2016). The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis. World Journal of Surgical Oncology. 14(1). 307–307. 13 indexed citations
19.
Du, Zhaopeng, Qingshang Yan, Yi Duan, et al.. (2005). Axial flow modulates proximal tubule NHE3 and H-ATPase activities by changing microvillus bending moments. American Journal of Physiology-Renal Physiology. 290(2). F289–F296. 64 indexed citations
20.
Sawada, Shigemasa, et al.. (1993). Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren’s syndrome. The Journal of Immunology. 150(8). 3615–3623. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Ben Larbi Breakdown of academic impact, for papers by Xiao Sun Breakdown of academic impact, for papers by Shanbao Cai Breakdown of academic impact, for papers by Amin El‐Heliebi Breakdown of academic impact, for papers by Ola Hadadeh Breakdown of academic impact, for papers by Zhao Cheng Breakdown of academic impact, for papers by Hanzhou Wang Breakdown of academic impact, for papers by Kathrine Woie Breakdown of academic impact, for papers by Robert Wirka Breakdown of academic impact, for papers by Xiangyu Zhou
Rankless by CCL
2026